Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords

Annals of Neurology

Volumn 68, Issue 4, 2010, Pages 465-476

  Androdias, Géraldine ^a,b,c   Reynolds, Richard ^d   Chanal, Marie ^a,b   Ritleng, Cécile ^b   Confavreux, Christian ^a,b,c   Nataf, Serge ^a,b,c  

^a National Institute for Medical Research U842   (France)

^b UNIVERSITÉ DE LYON   (France)

^c Pierre Wertheimer Neurological Hospital   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CYTOKINE; LEUKOCYTE ANTIGEN; MYELIN BASIC PROTEIN;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CERVICAL SPINAL CORD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE AXONAL INJURY; DISEASE COURSE; FEMALE; HUMAN; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MENINX; MICROGLIA; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; PARENCHYMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPINAL CORD; T LYMPHOCYTE; WHITE MATTER; CADAVER; CEREBROSPINAL FLUID; DEMYELINATING DISEASE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MYELITIS; NERVE FIBER; NEUTROPHIL CHEMOTAXIS; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY;

ADULT; ANTIGENS, CD; AXONS; CYTOKINES; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MENINGES; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELITIS; NEUTROPHIL INFILTRATION; POSTMORTEM CHANGES; SPINAL CORD; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES;

EID: 78149481589     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22054     Document Type: Article

References (27)

1. Confavreux C, Vukusic S,. Accumulation of irreversible disability in multiple sclerosis: from epidemiology to treatment. Clin Neurol Neurosurg 2006; 108: 327 332.
2. Storch M, Lassmann H,. Pathology and pathogenesis of demyelinating diseases. Curr Opin Neurol 1997; 10: 186 192.
3. Bjartmar C, Kidd G, Mork S, et al. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 893 901.
4. Ferguson B, Matyszak MK, Esiri MM, Perry VH,. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120 (pt 3): 393 399.
5. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278 285.
6. Lovas G, Szilagyi N, Majtenyi K, et al. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123 (pt 2): 308 317.
7. Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000; 47: 391 395.
8. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705 2712.
9. Frischer JM, Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175 1189.
10. Lin X, Tench CR, Turner B, et al. Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry 2003; 74: 1090 1094.
11. Ganter P, Prince C, Esiri MM,. Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol 1999; 25: 459 467.
12. DeLuca GC, Ebers GC, Esiri MM,. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 2004; 127: 1009 1018.
13. Evangelou N, DeLuca GC, Owens T, Esiri MM,. Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain 2005; 128: 29 34.
14. DeLuca GC, Williams K, Evangelou N, et al. The contribution of demyelination to axonal loss in multiple sclerosis. Brain 2006; 129: 1507 1516.
15. Tallantyre EC, Bo L, Al-Rawashdeh O, et al. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 2009; 132: 1190 1199.
16. Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130: 1089 1104.
17. Rasmussen S, Wang Y, Kivisakk P, et al. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing-remitting experimental autoimmune encephalomyelitis. Brain 2007; 130: 2816 2829.
18. Agosta F, Absinta M, Sormani MP, et al. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain 2007; 130: 2211 2219.
19. Raine CS, Mokhtarian F, McFarlin DE,. Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest 1984; 51: 534 546.
20. Cross AH, McCarron R, McFarlin DE, Raine CS,. Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observations on altered pathology by intercurrent virus infection. Lab Invest 1987; 57: 499 512.
21. Kooi EJ, van Horssen J, Witte ME, et al. Abundant extracellular myelin in the meninges of patients with multiple sclerosis. Neuropathol Appl Neurobiol 2009; 35: 283 295.
22. Dal Bianco A, Bradl M, Frischer J, et al. Multiple sclerosis and Alzheimer's disease. Ann Neurol 2008; 63: 174 183.
23. Chiu IM, Chen A, Zheng Y, et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A 2008; 105: 17913 17918.
24. Schwartz M, Butovsky O, Bruck W, Hanisch UK,. Microglial phenotype: is the commitment reversible? Trends Neurosci 2006; 29: 68 74.
25. Serafini B, Rosicarelli B, Franciotta D, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899 2912.
26. Franciotta D, Salvetti M, Lolli F, et al. B cells and multiple sclerosis. Lancet Neurol 2008; 7: 852 858.
27. Rovaris M, Confavreux C, Furlan R, et al. Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 2006; 5: 343 354.